We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-3.97%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$484B
AUM Growth
-$4.92B
Cap. Flow
+$23.6B
Cap. Flow %
4.87%
Top 10 Hldgs %
31.76%
Holding
15,382
New
1,669
Increased
5,510
Reduced
5,992
Closed
1,922

Sector Composition

Rank Sector Weight
1 Technology 2.72%
2 Healthcare 2.38%
3 Financials 2.3%
4 Consumer Discretionary 1.76%
5 Industrials 1.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VITL icon
11826
PUT
Vital Farms
VITL
$496M
$138K ﹤0.01%
11,200
-8,700
-44% -$131K
PAYA
11827
DELISTED
Paya Holdings Inc. Class A Common Stock
PAYA
$138K ﹤0.01%
23,557
-179,266
-88% -$1.08M
PEPLU
11828
DELISTED
PepperLime Health Acquisition Corporation Unit
PEPLU
$138K ﹤0.01%
13,543
-280
-2% -$2.85K
AFMD
11829
PUT
DELISTED
Affimed
AFMD
$137K ﹤0.01%
3,140
-770
-20% -$33.5K
BBAI icon
11830
PUT
BigBear.ai
BBAI
$1.6B
$137K ﹤0.01%
+16,600
New +$101K
DRRX
11831
CALL
DELISTED
DURECT Corp
DRRX
$137K ﹤0.01%
20,390
+10,980
+117% +$76.4K
GP
11832
GreenPower Motor Co
GP
$10.8M
$137K ﹤0.01%
2,002
-949
-32% -$60.6K
HITI
11833
CALL
High Tide
HITI
$206M
$137K ﹤0.01%
30,200
-6,300
-17% -$28.3K
JXG
11834
JX Luxventure
JXG
$88.9M
$137K ﹤0.01%
65
-25
-28% -$33.3K
FVT.U
11835
DELISTED
Fortress Value Acquisition Corp. III Units, each consisting of one share of Class A common stock and one-fifth of one Warrant
FVT.U
$137K ﹤0.01%
13,849
+270
+2% +$2.67K
CKPT
11836
PUT
DELISTED
Checkpoint Therapeutics
CKPT
$136K ﹤0.01%
7,660
+1,730
+29% +$37.2K
CLSK icon
11837
CleanSpark
CLSK
$2.96B
$136K ﹤0.01%
11,005
-773,798
-99% -$7.16M
LFST icon
11838
PUT
Lifestance Health
LFST
$4.39B
$136K ﹤0.01%
13,500
-4,600
-25% -$40.4K
TAC icon
11839
PUT
TransAlta
TAC
$3.95B
$136K ﹤0.01%
+13,100
New +$135K
SUAC.WS
11840
DELISTED
ShoulderUp Technology Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
SUAC.WS
$136K ﹤0.01%
+400,331
New +$167K
RYM
11841
PUT
RYTHM Inc
RYM
$45.7M
$135K ﹤0.01%
10
-4
-29% -$78.4K
ARDX icon
11842
CALL
Ardelyx
ARDX
$982M
$135K ﹤0.01%
126,500
-47,800
-27% -$42.7K
AXGN icon
11843
PUT
Axogen
AXGN
$2.61B
$135K ﹤0.01%
17,000
+2,100
+14% +$18.1K
GORO icon
11844
PUT
Goldgroup Mining Inc.
GORO
$184M
$135K ﹤0.01%
60,300
+17,800
+42% +$33K
GTBP icon
11845
GT Biopharma
GTBP
$11.3M
$135K ﹤0.01%
1,567
+1,186
+311% +$105K
HLX icon
11846
CALL
Helix Energy Solutions
HLX
$1.5B
$135K ﹤0.01%
28,300
+11,500
+68% +$47.2K
HUMA icon
11847
PUT
Humacyte
HUMA
$191M
$135K ﹤0.01%
19,100
-17,300
-48% -$101K
MCRB icon
11848
PUT
Seres Therapeutics
MCRB
$46.6M
$135K ﹤0.01%
945
-1,845
-66% -$284K
OCUL icon
11849
CALL
Ocular Therapeutix
OCUL
$2.14B
$135K ﹤0.01%
27,300
-82,100
-75% -$455K
GMDA
11850
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
$135K ﹤0.01%
32,577
-26,508
-45% -$88.9K

Similar funds

Citadel Advisors's Q1 2022 Portfolio in Review

As of Q1 2022, Citadel Advisors held 15,382 positions worth $484B, down 1% from $489B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Citadel Advisors deployed $23.6B of net new capital in Q1 2022, opening 1,669 new positions and adding to 5,510 existing holdings. Its largest new stake was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.

By sector, the portfolio is most concentrated in Technology at 2.7% of assets, down from 3.1% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was NVIDIA, an estimated $518M trimmed.

  • Citadel Advisors's largest Q1 2022 buy was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.
  • Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $555M increase.
  • Citadel Advisors's biggest Q1 2022 reduction was NVIDIA, cutting an estimated $518M.
  • Citadel Advisors fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $535M.
  • Citadel Advisors's ten largest holdings make up 32% of its $484B portfolio in Q1 2022.
  • Citadel Advisors opened 1,669 new positions and closed 1,922 in Q1 2022.
  • Citadel Advisors's portfolio value fell 1% quarter-over-quarter to $484B.

Based on Citadel Advisors's 13F filing for Q1 2022, filed 16 May 2022.